Which statement about late effects of chemotherapy is true?

• A. The age of the child, type of cancer, and treatment given may influence the development of late effects.
• B. Long-term effects should not be discussed with families at diagnosis because the majority of children diagnosed with cancer today will become long-term survivors.
• C. Late effects are not chronic effects of cancer and its treatment. Chemo only affects certain body systems.
• D. Chemo on affects the body at the time when it is administered and will not have later effects on the body systems.

Answer: (A)

Late effects are results that can emerge months or years after completing chemotherapy, and their occurrence depends on multiple interacting factors. The child’s age at treatment matters because younger developing bodies can be more vulnerable to growth, development, and reproductive system impacts. The type of cancer influences treatment intensity and specific regimens used, and the exact drugs and cumulative doses determine which organs might be at risk. For example, certain chemotherapies carry known risks to the heart, fertility, endocrine function, hearing, or the risk of future secondary cancers. Because these risks vary with who is treated and how they are treated, it’s realistic and important to acknowledge that late effects can differ from one child to another and may accumulate over time. This is why discussions about potential long-term effects are appropriate early in the care journey, so families can understand surveillance plans and monitor for problems as survivors.

Other statements don’t fit because late effects can be chronic and multi-system, not limited to the time of administration; discussing long-term risks at diagnosis helps with planning, not avoiding the topic; and chemo’s impact isn’t confined to the treatment period—delayed effects can appear long after therapy ends.